Follow
Vincent Mittelheisser
Vincent Mittelheisser
INSERM U1109
Verified email at etu.unistra.fr
Title
Cited by
Cited by
Year
Ral GTPases promote breast cancer metastasis by controlling biogenesis and organ targeting of exosomes
S Ghoroghi, B Mary, A Larnicol, N Asokan, A Klein, N Osmani, I Busnelli, ...
Elife 10, e61539, 2021
862021
Optimal physicochemical properties of antibody–nanoparticle conjugates for improved tumor targeting
V Mittelheisser, P Coliat, E Moeglin, L Goepp, JG Goetz, LJ Charbonnière, ...
Advanced Materials 34 (24), 2110305, 2022
232022
Anti‐BCMA Immuno‐NanoPET Radiotracers for Improved Detection of Multiple Myeloma
E Thomas, C Mathieu, P Moreno‐Gaona, V Mittelheisser, F Lux, ...
Advanced Healthcare Materials 11 (2), 2101565, 2022
52022
Helios represses megakaryocyte priming in hematopoietic stem and progenitor cells
G Cova, C Taroni, MC Deau, Q Cai, V Mittelheisser, M Philipps, M Jung, ...
Journal of Experimental Medicine 218 (10), e20202317, 2021
42021
Evidence and therapeutic implications of biomechanically regulated immunosurveillance in cancer and other diseases
V Mittelheisser, V Gensbittel, L Bonati, W Li, L Tang, JG Goetz
Nature Nanotechnology, 1-17, 2024
32024
Leveraging immunotherapy with nanomedicine
V Mittelheisser, M Banerjee, X Pivot, LJ Charbonnière, J Goetz, ...
Advanced Therapeutics 3 (12), 2000134, 2020
32020
Platelets favor the outgrowth of established metastases
MJ Garcia-Leon, O Lefebvre, G Follain, C Mouriaux, I Busnelli, A Larnicol, ...
bioRxiv, 2022.10. 28.514195, 2022
12022
Cell viscosity influences hematogenous dissemination and metastatic extravasation of tumor cells
V Gensbittel, G Follain, L Bochler, K Uhlmann, O Lefebvre, A Larnicol, ...
bioRxiv, 2024.03. 28.587171, 2024
2024
Targeting monocytic Occludin impairs monocyte transmigration and HIV neuroinvasion
D Brychka, NV Ayala-Nunez, Y Bare, A Dupas, E Partiot, V Mittelheisser, ...
bioRxiv, 2023.09. 11.557242, 2023
2023
Developing new strategies to control tumour progression-Targeting tumors or the immune system, a paradigm shift.
V Mittelheisser, O Lefebvre, R Soltani, S Ghosh, M Diringer, C Mathieu, ...
EUROPEAN JOURNAL OF IMMUNOLOGY 53, 173-173, 2023
2023
Age-related effects on tumor growth and metastatic progression: impact on immune populations in distant sites
C Liboni, L Bochler, F Colin, A Larnicol, V Mittelheisser, N Osmani, ...
EUROPEAN JOURNAL OF IMMUNOLOGY 53, 170-170, 2023
2023
P09. 22 Toward a rational design of immunonanotherapies
V Mittelheisser, X Coubez, O Lefebvre, JG Goetz, A Detappe
Journal for ImmunoTherapy of Cancer 10 (Suppl 1), 2022
2022
Conjugués anticorps-nanoparticules: nouvelles perspectives thérapeutiques en oncologie
V Mittelheisser
Faculté de Pharmacie, Université de Strasbourg, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–13